Clinical Trials
17 trialsNCT07623850 2026-06-03
JLM019
Jecho Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
NCT05272384 2026-05-13
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT06150664 2026-04-20
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Compass Therapeutics
Phase 1 Recruiting
NCT06176690 2026-04-13
CABAL2
Baylor College of Medicine
Phase 1 Recruiting
NCT06487624 2026-04-13
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
FBD Biologics Limited
Phase 1 Recruiting
NCT05544968 2026-04-03
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Phase 1 Recruiting
NCT07020533 2026-03-27
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
City of Hope Medical Center
Phase 1 Recruiting
NCT01555892 2026-03-02
GRALE
Baylor College of Medicine
Phase 1 Recruiting
NCT06755450 2026-01-13
ADITI-1
Aurigene Discovery Technologies Limited
Phase 1 Recruiting
NCT04664179 2025-12-12
CILESTE
Baylor College of Medicine
Phase 1 Recruiting
NCT02508038 2025-10-16
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
University of Wisconsin, Madison
Phase 1 Recruiting
NCT06383338 2025-09-08
PEGASUS
Murdoch Childrens Research Institute
Phase 1 Recruiting
NCT05798897 2025-08-20
APOLLO
Marker Therapeutics, Inc.
Phase 1 Recruiting
NCT02917083 2025-07-25
RELY-30
Baylor College of Medicine
Phase 1 Recruiting
NCT04288726 2025-07-20
Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas
Baylor College of Medicine
Phase 1 Recruiting
NCT05476770 2024-12-06
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1 Recruiting
NCT06494371 2024-07-10
A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma
Ruijin Hospital
Phase 1 Recruiting